Literature DB >> 7659775

Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.

A E Pegg1, M E Dolan, R C Moschel.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7659775     DOI: 10.1016/s0079-6603(08)60879-x

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


× No keyword cloud information.
  127 in total

1.  A phylogenomic study of DNA repair genes, proteins, and processes.

Authors:  J A Eisen; P C Hanawalt
Journal:  Mutat Res       Date:  1999-12-07       Impact factor: 2.433

2.  Crystal structure of the human O(6)-alkylguanine-DNA alkyltransferase.

Authors:  J E Wibley; A E Pegg; P C Moody
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

3.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.

Authors:  S R Mullapudi; F Ali-Osman; J Shou; K S Srivenugopal
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 5.  Protein-based tumor molecular imaging probes.

Authors:  Xin Lin; Jin Xie; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-17       Impact factor: 3.520

Review 6.  Alkyltransferase-like proteins: molecular switches between DNA repair pathways.

Authors:  Julie L Tubbs; John A Tainer
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

7.  Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.

Authors:  J R Silber; A Blank; M S Bobola; B A Mueller; D D Kolstoe; G A Ojemann; M S Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

8.  Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.

Authors:  Patrick-Denis St-Coeur; Julie J Poitras; Miroslava Cuperlovic-Culf; Mohamed Touaibia; Pier Morin
Journal:  J Neurooncol       Date:  2015-08-28       Impact factor: 4.130

9.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

10.  Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.

Authors:  Raymond P Baumann; Philip G Penketh; Kimiko Ishiguro; Krishnamurthy Shyam; Yong L Zhu; Alan C Sartorelli
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.